Sign up to save your podcasts
Or
Share Stopping of adalimumab in juvenile idiopathic arthritis-associated uveitis (ADJUST): a...
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Stopping of adalimumab in juvenile idiopathic arthritis-associated uveitis (ADJUST): a...
Stopping of adalimumab in juvenile idiopathic arthritis-associated uveitis (ADJUST): a multicentre, double-masked, randomised controlled trial
Hosted By: Mile Brujic, OD, FAAO
Topical Editor: Stephanie Stephanie Martich, OD, FAAO
Topical Expert: Valerie Baca, OD, FAAO
Publication: https://pubmed.ncbi.nlm.nih.gov/39863370/
View all episodes
By American Academy of Optometry Foundation
5
33 ratings
Stopping of adalimumab in juvenile idiopathic arthritis-associated uveitis (ADJUST): a multicentre, double-masked, randomised controlled trial
Hosted By: Mile Brujic, OD, FAAO
Topical Editor: Stephanie Stephanie Martich, OD, FAAO
Topical Expert: Valerie Baca, OD, FAAO
Publication: https://pubmed.ncbi.nlm.nih.gov/39863370/
More shows like AAOF Clinical Podcast Series
View all
Power Hour Optometry
77 Listeners
Optometric Insights Media
21 Listeners
The 20/20 Podcast
8 Listeners